These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33421056)

  • 61. Rapid reinfection with SARS-CoV-2 variant-of-concern Alpha detected in a nurse during an outbreak at a non-covid inpatient ward: lessons learned.
    Koopsen J; Dekker M; Thung P; Jonges M; Vennema H; Leenstra T; Eggink D; Welkers MRA; Struijs PAA; Reusken C; van Mansfeld R; de Jong MD; Schinkel J; Spijkerman IJB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):137. PubMed ID: 34565476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around.
    Kim AY; Gandhi RT
    Clin Infect Dis; 2021 Nov; 73(9):e3009-e3012. PubMed ID: 33035308
    [No Abstract]   [Full Text] [Related]  

  • 63. Emerging COVID-19 reinfection four months after primary SARS-CoV-2 infection.
    Salzer HJF; Neuböck M; Heldt S; Haug I; Paar C; Lamprecht B
    Wien Med Wochenschr; 2022 Mar; 172(3-4):74-76. PubMed ID: 33555412
    [No Abstract]   [Full Text] [Related]  

  • 64. Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
    Zucman N; Uhel F; Descamps D; Roux D; Ricard JD
    Clin Infect Dis; 2021 Nov; 73(10):1945-1946. PubMed ID: 33566076
    [No Abstract]   [Full Text] [Related]  

  • 65. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    Adrielle Dos Santos L; Filho PGG; Silva AMF; Santos JVG; Santos DS; Aquino MM; de Jesus RM; Almeida MLD; da Silva JS; Altmann DM; Boyton RJ; Alves Dos Santos C; Santos CNO; Alves JC; Santos IL; Magalhães LS; Belitardo EMMA; Rocha DJPG; Almeida JPP; Pacheco LGC; Aguiar ERGR; Campos GS; Sardi SI; Carvalho RH; de Jesus AR; Rezende KF; de Almeida RP
    J Infect; 2021 Mar; 82(3):399-406. PubMed ID: 33589297
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fast-spreading COVID variant can elude immune responses.
    Callaway E
    Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
    [No Abstract]   [Full Text] [Related]  

  • 69. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Muik A; Wallisch AK; Sänger B; Swanson KA; Mühl J; Chen W; Cai H; Maurus D; Sarkar R; Türeci Ö; Dormitzer PR; Şahin U
    Science; 2021 Mar; 371(6534):1152-1153. PubMed ID: 33514629
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    Breathnach AS; Riley PA; Cotter MP; Houston AC; Habibi MS; Planche TD
    J Infect; 2021 Apr; 82(4):e11-e12. PubMed ID: 33450303
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
    Jangra S; Ye C; Rathnasinghe R; Stadlbauer D; ; Krammer F; Simon V; Martinez-Sobrido L; García-Sastre A; Schotsaert M
    medRxiv; 2021 Jan; ():. PubMed ID: 33532796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    Tang JW; Toovey OTR; Harvey KN; Hui DDS
    J Infect; 2021 Apr; 82(4):e8-e10. PubMed ID: 33472093
    [No Abstract]   [Full Text] [Related]  

  • 73. COVID reinfections are unusual - but could still help the virus to spread.
    Ledford H
    Nature; 2021 Jan; ():. PubMed ID: 33441993
    [No Abstract]   [Full Text] [Related]  

  • 74. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.
    Bal A; Destras G; Gaymard A; Stefic K; Marlet J; Eymieux S; Regue H; Semanas Q; d'Aubarede C; Billaud G; Laurent F; Gonzalez C; Mekki Y; Valette M; Bouscambert M; Gaudy-Graffin C; Lina B; Morfin F; Josset L;
    Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478625
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evolution of antibody immunity to SARS-CoV-2.
    Gaebler C; Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Tokuyama M; Cho A; Jankovic M; Schaefer-Babajew D; Oliveira TY; Cipolla M; Viant C; Barnes CO; Bram Y; Breton G; Hägglöf T; Mendoza P; Hurley A; Turroja M; Gordon K; Millard KG; Ramos V; Schmidt F; Weisblum Y; Jha D; Tankelevich M; Martinez-Delgado G; Yee J; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Robbiani DF; Zhao Z; Gazumyan A; Schwartz RE; Hatziioannou T; Bjorkman PJ; Mehandru S; Bieniasz PD; Caskey M; Nussenzweig MC
    Nature; 2021 Mar; 591(7851):639-644. PubMed ID: 33461210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.
    Xie X; Zou J; Fontes-Garfias CR; Xia H; Swanson KA; Cutler M; Cooper D; Menachery VD; Weaver S; Dormitzer PR; Shi PY
    bioRxiv; 2021 Jan; ():. PubMed ID: 33442691
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.
    Dimeglio C; Herin F; Miedougé M; Martin-Blondel G; Soulat JM; Izopet J
    Clin Infect Dis; 2021 Oct; 73(7):1323-1324. PubMed ID: 33503228
    [No Abstract]   [Full Text] [Related]  

  • 78. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.
    Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
    bioRxiv; 2021 Feb; ():. PubMed ID: 33532778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
    Maggi F; Novazzi F; Genoni A; Baj A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Azzi L; Donadini A; Catanoso G; Grossi PA; Maffioli L; Bonelli G
    Emerg Infect Dis; 2021 Apr; 27(4):1249-1251. PubMed ID: 33567246
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.